![Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology](https://www.thelancet.com/cms/attachment/aebe7284-f489-4fa5-a13d-db5ed5bcba73/gr2_lrg.jpg)
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology
![Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology](https://www.thelancet.com/cms/attachment/a09fc8f1-7828-419f-8057-419f72a287d4/gr3.jpg)
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology
![Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology](https://www.thelancet.com/cms/attachment/34b2410d-db54-46e1-ac1d-1d1894292938/gr1_lrg.gif)
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology
![Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy | Modern Pathology Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy | Modern Pathology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fmodpathol.2015.53/MediaObjects/41379_2015_Article_BFmodpathol201553_Fig1_HTML.jpg)
Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy | Modern Pathology
![Determination of breast cancer prognosis after neoadjuvant chemotherapy: comparison of Residual Cancer Burden (RCB) and Neo-Bioscore | British Journal of Cancer Determination of breast cancer prognosis after neoadjuvant chemotherapy: comparison of Residual Cancer Burden (RCB) and Neo-Bioscore | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41416-020-01251-3/MediaObjects/41416_2020_1251_Fig1_HTML.png)
Determination of breast cancer prognosis after neoadjuvant chemotherapy: comparison of Residual Cancer Burden (RCB) and Neo-Bioscore | British Journal of Cancer
![Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy | Modern Pathology Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy | Modern Pathology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fmodpathol.2015.53/MediaObjects/41379_2015_Article_BFmodpathol201553_Fig3_HTML.jpg)
Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy | Modern Pathology
Prognostic value of the Residual Cancer Burden index according to breast cancer subtype: Validation on a cohort of BC patients treated by neoadjuvant chemotherapy | PLOS ONE
![Good practice: The experiences with the utilization of residual cancer burden—A single institution study - Sejben - 2023 - Thoracic Cancer - Wiley Online Library Good practice: The experiences with the utilization of residual cancer burden—A single institution study - Sejben - 2023 - Thoracic Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/b93ba2fb-ed63-4854-8cb2-511ef0a8ab71/tca14826-toc-0001-m.jpg?trick=1701686030800)
Good practice: The experiences with the utilization of residual cancer burden—A single institution study - Sejben - 2023 - Thoracic Cancer - Wiley Online Library
![Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant Therapy | Annals of Surgical Oncology Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant Therapy | Annals of Surgical Oncology](https://media.springernature.com/m685/springer-static/image/art%3A10.1245%2Fs10434-019-07741-w/MediaObjects/10434_2019_7741_Fig2_HTML.png)
Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant Therapy | Annals of Surgical Oncology
![Good practice: The experiences with the utilization of residual cancer burden—A single institution study - Sejben - 2023 - Thoracic Cancer - Wiley Online Library Good practice: The experiences with the utilization of residual cancer burden—A single institution study - Sejben - 2023 - Thoracic Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/5b78c760-89fe-4e8c-b4ff-aa91643515ef/tca.v14.11.cover.jpg)
Good practice: The experiences with the utilization of residual cancer burden—A single institution study - Sejben - 2023 - Thoracic Cancer - Wiley Online Library
![Stefania Landolfi on X: "Residual Cancer Burden evaluation in post-NAST #Breastpath #USCAP2018 #insitupathologists https://t.co/4GSxTI47S5" / X Stefania Landolfi on X: "Residual Cancer Burden evaluation in post-NAST #Breastpath #USCAP2018 #insitupathologists https://t.co/4GSxTI47S5" / X](https://pbs.twimg.com/media/DYlT9WBVoAA6vFS.jpg)
Stefania Landolfi on X: "Residual Cancer Burden evaluation in post-NAST #Breastpath #USCAP2018 #insitupathologists https://t.co/4GSxTI47S5" / X
![Automated and Manual Quantification of Tumour Cellularity in Digital Slides for Tumour Burden Assessment | Scientific Reports Automated and Manual Quantification of Tumour Cellularity in Digital Slides for Tumour Burden Assessment | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-50568-4/MediaObjects/41598_2019_50568_Fig1_HTML.png)